Diagnosing stage 2 mesothelioma involves imaging tests and tissue biopsies. Initial X-rays might reveal fluid buildup around the lungs or abdomen, but more detailed imaging methods like CT scans and MRIs are essential to determine the tumor's size and extent of spread. A biopsy, where a tissue sample is examined under a microscope, confirms the presence of mesothelioma. This is usually done through minimally invasive procedures such as thoracoscopy or laparoscopy, depending on whether the tumor affects the chest or abdominal cavity. Because symptoms can resemble less serious illnesses at this stage, early diagnosis can be challenging but is crucial for effective treatment.
When it comes to treatment, stage 2 mesothelioma generally remains manageable with a combination of therapies. Surgery, such as pleurectomy with decortication (P/D) — which removes part of the lining around the lungs while sparing the lung itself — offers a chance to remove tumors while preserving organ function. More aggressive surgeries, like extrapleural pneumonectomy (EPP), involve removing the affected lung but are less common due to their complexity. Alongside surgery, chemotherapy, immunotherapy, and radiation are often used to shrink tumors, prevent recurrence, and improve quality of life. Although there is currently no cure for mesothelioma, these combined approaches can extend survival, with recent studies showing patients living beyond two years after diagnosis. Consulting with specialized mesothelioma treatment centers can significantly enhance the chances of achieving the best possible outcomes at this stage.
